Review of precision cancer medicine: Evolution of the treatment paradigm
Apostolia M. Tsimberidou(The University of Texas MD Anderson Cancer Center), Razelle Kurzrock(Medical College of Wisconsin), Mina Nikanjam(UC San Diego Health System), Elena Fountzilas(St. Luke's Hospital)
Cited by 747
Related Papers
Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers
|Molecular Cancer Therapeutics|2017|2.4k
PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
|Molecular Cancer Therapeutics|2015|2.3k
Circulating Tumor DNA Analysis in Patients With Cancer: American Society of Clinical Oncology and College of American Pathologists Joint Review
|Journal of Clinical Oncology|2018|925
Epstein-Barr Virus and Cancer
|Clinical Cancer Research|2004|795
Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study
|Nature Medicine|2019|710